Annexin A10 is a candidate marker associated with the progression of pancreatic precursor lesions to adenocarcinoma
Table 2
ANXA10 and CD24 positive rates as well as the co-expression rate in normal pancreas, cancer adjacent normal pancreas tissues, chronic pancreatitis, PanINs, IPMNs, and PDACs, respectively.